{
    "b0": "Improved survival with ipilimumab in patients with metastatic melanoma",
    "b1": "Nivolumab in previously untreated melanoma without BRAF mutation",
    "b2": "Combined nivolumab and ipilimumab or monotherapy in untreated melanoma",
    "b3": "Immune-related adverse events with immune checkpoint blockade: a comprehensive review",
    "b4": "randomized selection design trial evaluating cd8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma",
    "b5": "Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells",
    "b6": "Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer",
    "b7": "human epidermal growth factor receptor 2 (her2) -specific chimeric antigen receptor-modified t cells for the immunotherapy of her2-positive sarcoma",
    "b8": "Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy",
    "b9": "Adoptive cell transfer as personalized immunotherapy for human cancer",
    "b10": "Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients",
    "b11": "Effective clinical responses in metastatic melanoma patients after vaccination with primary myeloid dendritic cells",
    "b12": "Vaccines for established cancer: overcoming the challenges posed by immune evasion",
    "b13": "An overview of sipuleucel-T: autologous cellular immunotherapy for prostate cancer",
    "b14": "Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer",
    "b15": "controlled local delivery of ctla-4 blocking antibody induces cd8+ t-cell-dependent tumor eradication and decreases risk of toxic side effects",
    "b16": "Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo",
    "b17": "Local targets for immune therapy to cancer: tumor draining lymph nodes and tumor microenvironment",
    "b18": "Intratumoral immunization: a new paradigm for cancer therapy",
    "b19": "Targeting the tumor microenvironment to enhance antitumor immune responses",
    "b20": "The tumor-draining lymph node as an immune-privileged site",
    "b21": "Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion",
    "b22": "Immune resistance orchestrated by the tumor microenvironment",
    "b23": "Cellular and molecular mechanisms in cancer immune escape: a comprehensive review",
    "b24": "The immune contexture in human tumours: impact on clinical outcome",
    "b25": "quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes",
    "b26": "Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma",
    "b27": "Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer",
    "b28": " analysis of foxp3+ regulatory t cells and myeloid dendritic cells in human colorectal cancer tissue and tumor-draining lymph node",
    "b29": "Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention",
    "b30": "Challenges in tissue engineering",
    "b31": "Efficiency of dendritic cell vaccination against B16 melanoma depends on the immunization route",
    "b32": "Therapeutic use of dendritic cells to promote the extranodal priming of anti-tumor immunity",
    "b33": "Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy",
    "b34": "Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy",
    "b35": "modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors",
    "b36": "activated dendritic cells delivered in tissue compatible biomatrices induce in-situ anti-tumor ctl responses leading to tumor regression",
    "b37": "Thermoreversible poly(ethylene glycol)-g-chitosan hydrogel as a therapeutic T lymphocyte depot for localized glioblastoma immunotherapy",
    "b38": "Chitosan thermogels for local expansion and delivery of tumor-specific T lymphocytes towards enhanced cancer immunotherapies",
    "b39": "Biopolymer implants enhance the efficacy of adoptive T-cell therapy",
    "b40": "In situ modulation of dendritic cells by injectable thermosensitive hydrogels for cancer vaccines in mice",
    "b41": "Infection-mimicking materials to program dendritic cells in situ",
    "b42": "Biomaterial-based vaccine induces regression of established intracranial glioma in rats",
    "b43": "Vaccines combined with immune checkpoint antibodies promote cytotoxic T-cell activity and tumor eradication",
    "b44": "Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants",
    "b45": "Inflammatory cytokines presented from polymer matrices differentially generate and activate DCs in situ",
    "b46": "Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy",
    "b47": "Injectable preformed scaffolds with shape-memory properties",
    "b48": "Shear-thinning hydrogels for biomedical applications",
    "b49": "Injectable cryogel-based whole-cell cancer vaccines",
    "b50": "In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells",
    "b51": "an injectable synthetic immune-priming center mediates efficient t-cell class switching and t-helper 1 response against b cell lymphoma",
    "b52": "Local release of highly loaded antibodies from functionalized nanoporous support for cancer immunotherapy",
    "b53": "Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma",
    "b54": "Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy",
    "b55": "targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response",
    "b56": "Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes",
    "b57": "Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists",
    "b58": "arming the melanoma sentinel lymph node through local administration of cpg-b and gm-csf: recruitment and activation of bdca3/cd141(+) dendritic cells and enhanced cross-presentation",
    "b59": "Local delivery of CpG-B and GM-CSF induces concerted activation of effector and regulatory T cells in the human melanoma sentinel lymph node",
    "b60": "Talimogene laherparepvec improves durable response rate in patients with advanced melanoma",
    "b61": "Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study",
    "b62": "In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study",
    "b63": "In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study",
    "b64": "Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer",
    "b65": "Local activation of CD8 T cells and systemic tumor eradication without toxicity via slow release and local delivery of agonistic CD40 antibody",
    "b66": "Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation",
    "b67": "Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?",
    "b68": "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy",
    "b69": "In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags",
    "b70": "CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses",
    "b71": "targeted plga nano- but not microparticles specifically deliver antigen to human dendritic cells via dc-sign in vitro",
    "b72": "Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells",
    "b73": "dendritic cells in tumor-associated tertiary lymphoid structures signal a th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating cd8+ t cells",
    "b74": "localized immunotherapy via liposome-anchored anti-cd137 + il-2 prevents lethal toxicity and elicits local and systemic antitumor immunity",
    "b75": "Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy",
    "b76": "PLGA-nanoparticle mediated delivery of anti-OX40 monoclonal antibody enhances anti-tumor cytotoxic T cell responses",
    "b77": "Combination delivery of TGF-\u03b2 inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy",
    "b78": "Injectable hyaluronic acid-tyramine hydrogels incorporating interferon-\u03b12a for liver cancer therapy",
    "b79": "Efficient nontoxic delivery of PD-L1 and PD-L2 siRNA into dendritic cell vaccines using the cationic lipid SAINT-18",
    "b80": "ovarian cancer immunotherapy using pd-l1 sirna targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance t cell killing",
    "b81": "Engineering vaccines and niches for immune modulation",
    "b82": "Biomaterial strategies for immunomodulation",
    "b83": "The effect of combined IL10 siRNA and CpG ODN as pathogen-mimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity against B cell lymphoma",
    "b84": "Generation of a synthetic lymphoid tissue-like organoid in mice",
    "b85": "Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice",
    "b86": "Gel-trapped lymphorganogenic chemokines trigger artificial tertiary lymphoid organs and mount adaptive immune responses in vivo",
    "b87": "Facilitating T cell infiltration in tumor microenvironment overcomes resistance to PD-L1 blockade",
    "b88": "Engineering of synthetic cellular microenvironments: implications for immunity",
    "b89": "Designing regenerative biomaterial therapies for the clinic",
    "b90": "US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/show/NCT01753089"
}